IL15 and breast carcinoma: In terms of the cancer microenvironment, systemic IL-15 treatment reduced tumor growth, metastasis, and recurrence by increasing the cytotoxic effects of NK cells in mice inoculated with a lung and breast cancer models (Tang et al., 2008; Gillgrass et al., 2014).